Veterinary Medicines

ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα

Authorised
  • ALBENDAZOLE
Download as PDF

Auðkenning lyfsins

Heiti lyfs:
ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα
Virkt efni:
Dýrategundir:
  • Sauðkind
Íkomuleið:
  • Til inntöku

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    300.00
    milligram(s)
    /
    1.00
    Tafla
Lyfjaform:
  • Tafla
Withdrawal period by route of administration:
  • Oral use
    • Sauðkind
      • Kjöt og innmatur
        10
        dagar
      • Mjólk
        5
        dagar
ATC flokkun (dýralyf):
  • QP52AC11
Lögformleg staða:
Staða markaðsleyfis:
  • Gilt
Authorised in:
Þessar upplýsingar eru ekki tiltækar fyrir þessa vöru.
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Lagagrundvöllur vöruleyfis:
Markaðsleyfishafi:
  • Anafasis Limited
Markaðsleyfi gefið út:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Uplab Pharmaceutical Company Ltd.
Útgáfuland markaðsleyfis:
  • Grikkland
Ábyrgt yfirvald:
  • National Organization For Medicines
Markaðsleyfisnúmer:
  • 95613/20-10-2021/K-0160301
Dagsetning leyfisbreytingar:

Skjöl

Samantekt á eiginleikum lyfs

Published:
Greek (PDF)
Download

Fylgiseðill

Published:
Greek (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."